Home › Focal Segmental Glomerulosclerosis › Ohio › Cleveland
Focal Segmental Glomerulosclerosis clinical trials in Cleveland, OH
4 studies for Focal Segmental Glomerulosclerosis are looking for participants at sites in and around Cleveland (within about 30 miles). Open a study to see who can join and how to contact the study team.
A Study to Evaluate the Efficacy and Safety of Frexalimab, Brivekimig, or Rilzabrutinib in Participants Aged 16 to 75 Years With Primary Focal Segmental Glomerulosclerosis or Minimal Change Disease
RecruitingPhase 2
- Cleveland Clinic - Cleveland- Site Number : 8400029, Cleveland
A Study of Praliciguat in Participants With Focal Segmental Glomerulosclerosis (FSGS)
RecruitingPhase 2
- Investigator Site #20, Cleveland
NEPTUNE Match Study
Recruiting
- Cleveland Clinic Foundation, Cleveland
Nephrotic Syndrome Study Network
RecruitingObservational study
- Cleveland Clinic, Cleveland
Focal Segmental Glomerulosclerosis trials in other cities
- Philadelphia, PA9 studies
- Durham, NC8 studies
- New York City, NY7 studies
- Miami, FL6 studies
- Queens, NY6 studies
- Los Angeles, CA6 studies
- Ann Arbor, MI6 studies
- Atlanta, GA5 studies
- Houston, TX5 studies
- Chicago, IL4 studies
- Kansas City, MO4 studies
- Dallas, TX4 studies
Other studies in Cleveland
- Non-Small Cell Lung Cancer44 studies
- Cancer (all types)37 studies
- Breast Cancer35 studies
- Prostate Cancer34 studies
- Heart Failure33 studies
- Metastatic Cancer30 studies
- Ovarian Cancer28 studies
- Lung Cancer26 studies
- Colorectal Cancer24 studies
- Cardiovascular Disease22 studies
- Endometrial Cancer21 studies
- Acute Myeloid Leukemia20 studies
From ClinicalTrials.gov, data retrieved Sep 30, 2026. Each study sets its own eligibility; the study team decides who can join.